Repligen (RGEN) Change in Accured Expenses (2010 - 2026)

Repligen (RGEN) has reported Change in Accured Expenses for 17 consecutive years, with $12.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 352.56% year-over-year to $12.1 million; the TTM figure through Jun 2026 stood at $14.3 million (up 1576.17% YoY), while the FY2025 annual figure was $11.8 million, up 93.47% from the prior year.
• Change in Accured Expenses improved to $12.1 million in Q2 2026 per RGEN's latest filing, from -$12.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $12.6 million in Q3 2025 and bottomed at -$12.7 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$341388.9 across 5 years, with a median of $12500.0 in 2024.
• Annual changes were most pronounced in 2024 — Change in Accured Expenses soared 516.24% — and 2026, when it tumbled 800.33%.
• Repligen's Change in Accured Expenses stood at -$5.1 million in 2022, then sank by 77.87% to -$9.0 million in 2023, then surged by 108.29% to $746000.0 in 2024, then soared by 192.76% to $2.2 million in 2025, then jumped by 455.31% to $12.1 million in 2026.
• Business Quant data shows RGEN's Change in Accured Expenses at $12.1 million in Q2 2026, -$12.7 million in Q1 2026, and $2.2 million in Q4 2025.